Alzheimer's Disease Research

Alzheimer's disease is an irreversible, progressive brain disease that slowly destroys memory and thinking skills, eventually leaving the person without the ability to carry out the simplest tasks of daily living. Estimates vary, but experts suggest that as many as 5 million Americans age 65 and older have Alzheimer's disease. Research works on ways to improve diagnosis and care for Alzheimer’s disease patients, as well as focusing on a way to cure and possibly prevent it.

Search

Clinical Trials

APOLLOE4

STATUS: Active, Not Recruiting

247AD201 CELIA

STATUS: Active, Not Recruiting

NVI-039 AD

STATUS: Active, Recruiting

ALZ-NET

STATUS: Active, Recruiting

Life Molecular LMT-01-01-22

STATUS: Active, Recruiting

View all Clinical Trials

Publications

Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease

Reduction of Amyloid in the Brain and Retina After Treatment With IVIG for Mild Cognitive Impairment

IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia

Alzheimer abnormalities of the amygdala with Klüver-Bucy syndrome symptoms: an amygdaloid variant of Alzheimer disease

View all Publications

Research Studies

Stupski Serious Illness Program Evaluation

All Research Studies

Featured Investigator

Sylvia Sudat

PhD

Dr. Sudat is a Sutter Health Epic data and analytic expert, and an informal content leader for the analytics team at Sutter’s Center for Health Systems Research

Meet Sylvia Sudat

Patients and Visitors

My Health Online

Patient Resources

Billing and Insurance

Treatments and Services

Schedule a Visit

Get Care

Featured Services

Research and Education

Graduate Medical Education

Research

Education

About Us

Work at Sutter Health

About Sutter Health

Community

Careers

Alzheimer's Disease Research

Search

Clinical Trials

Publications

Research Studies

Featured Investigator